Related Experiment Video
Updated: Jun 29, 2025

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
A missense mutation in human INSC causes peripheral neuropathy.
Jui-Yu Yeh1, Hua-Chuan Chao2,3,4, Cheng-Li Hong1
1Graduate Institute of Physiology, National Taiwan University, Taipei, Taiwan.
A mutation in the INSC gene causes Charcot-Marie-Tooth disease type 2 (CMT2) by disrupting the PAR3/INSC/LGN complex in the peripheral nervous system (PNS). Microtubule-stabilizing drugs may offer a therapeutic approach for this neurodegenerative disorder.
Area of Science:
- Neuroscience
- Cell Biology
- Genetics
Background:
- The PAR3/INSC/LGN complex is crucial for brain development but its role in the adult peripheral nervous system (PNS) is unclear.
- Axonal Charcot-Marie-Tooth disease (CMT2) is a progressive neurodegenerative disorder affecting peripheral nerves.
Purpose of the Study:
- To investigate the function of the PAR3/INSC/LGN complex in the adult PNS.
- To identify the genetic basis and cellular mechanisms of a novel form of CMT2.
Main Methods:
- Genetic mapping to identify a new CMT2 locus.
- In silico and in vivo modeling of an INSC gene mutation (p.Met70Arg) in Drosophila.
- Cellular analysis of neurodegeneration and tubulin aggregation.
- Assessment of therapeutic efficacy using microtubule-stabilizing agents.
Main Results:
- A missense mutation in the INSC gene was identified as a cause of axonal CMT2.
- The INSCM70R mutation in Drosophila induced proprioceptive and gait defects, mimicking human CMT2 symptoms.
- Cellular studies revealed tubulin aggregation and neurodegeneration due to PAR3/INSC/LGN dysfunction.
- Microtubule-stabilizing agents ameliorated the observed defects.
Conclusions:
- The PAR3/INSC/LGN complex is vital for the maintenance of the adult PNS.
- INSC mutations can lead to CMT2 through impaired microtubule dynamics and neurodegeneration.
- Targeting microtubule stabilization presents a potential therapeutic strategy for INSC-associated CMT2.
More Related Videos
07:43Modeling Charcot-Marie-Tooth Disease In Vitro by Transfecting Mouse Primary Motoneurons
Published on: January 7, 2019
06:35In Vivo Electrophysiological Measurement of Compound Muscle Action Potential from the Forelimbs in Mouse Models of Motor Neuron Degeneration
Published on: June 15, 2018
Related Concept Videos
Mutations
Nonsense-mediated mRNA Decay
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...